Trikafta May Be Safe and Effective for Liver Transplant Patients

Trikafta May Be Safe and Effective for Liver Transplant Patients

314336

Trikafta May Be Safe and Effective for Liver Transplant Patients

People with cystic fibrosis (CF) who had a liver transplant can be safely started on Trikafta (elexacaftor/tezacaftor/ivacaftor), a small study suggests. For most patients in the study, Trikafta’s use resulted in an easing of symptoms, better quality of life, and healthier body weight and lung function. Doctors with the CF and transplant teams should work together in closely monitoring a patient’s progress to “ensure safe initiation and balance overall expectations of treatment,” the study’s researchers wrote.…

You must be logged in to read/download the full post.